Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Demis Hassabis on Isomorphic’s $600 million raise, AI, and healthcare’s future
In AI, games are more than just fun—they can reconceive what’s possible. Demis Hassabis, cofounder of DeepMind and 2024 ...
Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
BioPharma Dive2d
Isomorphic raises $600M on big ambitions for AI drugmaking tech
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Fierce Biotech3d
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
GEN - Genetic Engineering and Biotechnology News2d
DeepMind Spinout Isomorphic Labs Raises $600M Toward AI Drug Design
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...